Keywords: Vectura, Novartis, Sandoz, VR315, Asthma, Advair, GlaxoSmithKline

Vectura gets $9.5 million payoff as Novartis returns US rights to VR315

Article | 19 March 2010

Print This

The UK’s Vectura Group saw its shares plummet as much as 20% (settling the day down around 18% at 52.75 pence) after ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in